StockNews.com initiated coverage on shares of Revvity (NYSE:PKI – Get Rating) in a research report released on Monday. The firm issued a hold rating on the medical research company’s stock. Other equities research analysts have also issued reports about the company. TheStreet lowered Revvity from a b- rating to a c rating in a research […]
StockNews.com initiated coverage on shares of Revvity (NYSE:PKI – Get Rating) in a research note released on Sunday. The brokerage issued a hold rating on the medical research company’s stock. Several other brokerages have also issued reports on PKI. Stifel Nicolaus decreased their price target on shares of Revvity from $145.00 to $135.00 in a […]
StockNews.com initiated coverage on shares of Revvity (NYSE:PKI – Get Rating) in a research report released on Sunday. The brokerage issued a hold rating on the medical research company’s stock. Several other research firms have also recently weighed in on PKI. Citigroup decreased their price objective on shares of Revvity from $170.00 to $160.00 in […]
Equities research analysts at StockNews.com initiated coverage on shares of Revvity (NYSE:PKI – Get Rating) in a research note issued to investors on Sunday. The firm set a “hold” rating on the medical research company’s stock. PKI has been the topic of several other reports. Citigroup decreased their target price on shares of Revvity from […]
Revvity (NYSE:RVTY – Get Rating) is one of 44 publicly-traded companies in the “Analytical instruments” industry, but how does it compare to its peers? We will compare Revvity to related companies based on the strength of its risk, profitability, earnings, analyst recommendations, institutional ownership, dividends and valuation. Risk & Volatility Revvity has a beta of […]